Driehaus Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-257,371
| Closed | -$3.01M | – | 428 |
|
|
2024
Q2 | $3.01M | Buy |
257,371
+74,074
| +40% | +$867K | 0.03% | 278 |
|
|
2024
Q1 | $2.37M | Sell |
183,297
-22,968
| -11% | -$297K | 0.02% | 298 |
|
|
2023
Q4 | $1.77M | Sell |
206,265
-295,109
| -59% | -$2.54M | 0.02% | 301 |
|
|
2023
Q3 | $4.77M | Buy |
501,374
+1,391
| +0.3% | +$13.2K | 0.06% | 286 |
|
|
2023
Q2 | $8.52M | Buy |
499,983
+46,982
| +10% | +$801K | 0.11% | 229 |
|
|
2023
Q1 | $7.09M | Buy |
+453,001
| New | +$7.09M | 0.1% | 263 |
|